Close
4
Promoted Content
Promoted Content

Company profile for Viralytics Limited

Client EmailClient Virtual Booth
VIRALYTICS LIMITED
  • Connect with Us...

PharmaCompass
About the Company
Viralytics is focused on the development and commercialisation of oncolytic immunotherapies that harness the power of certain viruses to preferentially infect and kill cancer cells. Our lead product candidate is CAVATAK®, a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21, now being evaluated in multiple clinical trials. CAVATAK binds to specific receptor proteins highly expressed on a...
Viralytics is focused on the development and commercialisation of oncolytic immunotherapies that harness the power of certain viruses to preferentially infect and kill cancer cells. Our lead product candidate is CAVATAK®, a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21, now being evaluated in multiple clinical trials. CAVATAK binds to specific receptor proteins highly expressed on a range of tumour cell types, and acts to destroy local as well as metastatic cancer cells through cell lysis and the potential generation of a specific immune response against the cancer cells.
Upgrade the company profile

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Viralytics Limited
Australia Flag
Country
Country
AUSTRALIA
Address
Address
Viaduktstrasse 8 4051 Basel
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter
Client Virtual Booth

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Learn More About